Business Context and Reporting Period
Company: Launch One Acquisition Corp. (LPAA), a Cayman Islands exempted company and Special Purpose Acquisition Company (SPAC).
Reporting Period: Quarterly period ended June 30, 2026.
Status: The Company is an early-stage emerging growth company with no operating revenue. It is searching for a target business to consummate an initial Business Combination. The deadline to complete a combination was extended to January 15, 2027, following a shareholder vote in July 2026.
Key Financial Metrics
| Metric | Six Months Ended June 30, 2026 | Three Months Ended June 30, 2026 |
|---|---|---|
| Net Income | $3,299,893 | $1,599,821 |
| General & Administrative Expenses | $1,061,223 | $593,448 |
| Interest Income (Trust Account) | $4,361,100 | $2,193,256 |
| Cash (Operating) | $321,957 (as of June 30, 2026) | N/A |
| Trust Account Balance | $249,810,453 (as of June 30, 2026) | N/A |
| Working Capital Deficit | $1,671,168 (as of June 30, 2026) | N/A |
| Debt (Working Capital Note) | $1,046,959 (carrying value) | N/A |
Material Changes vs. Prior Period
- Net Income Decline: Net income for the six months ended June 30, 2026, was $3.30 million, a decrease from $4.21 million in the same period in 2025. This was primarily due to lower interest earned on the Trust Account ($4.36 million vs. $5.00 million) and the absence of unrealized gains on marketable securities recorded in the prior year.
- Expense Increase: General and administrative expenses increased to $1.06 million for the six months ended June 30, 2026, compared to $0.82 million in the prior year period.
- Debt Issuance: The Company issued a $1.0 million Working Capital Note to its Sponsor in March 2026 to fund operations, resulting in a new liability not present in the prior comparable period.
- Transaction Termination: The Company terminated its Business Combination Agreement with Minovia Therapeutics Ltd. on January 30, 2026.
Outlook, Risks, and Unusual Items
- Extension and Redemptions: In July 2026, shareholders approved an extension of the Business Combination deadline to January 15, 2027. Approximately 21.2 million Public Shares were redeemed, removing roughly $229.9 million from the Trust Account. Only 1.77 million Public Shares remain outstanding.
- Going Concern: Management has raised substantial doubt about the Company's ability to continue as a going concern due to liquidity constraints and the mandatory liquidation date if a Business Combination is not completed by January 15, 2027.
- Deferred Underwriting Fee: A deferred fee of $10.95 million is payable to underwriters upon the completion of a Business Combination.
- Shareholder Structure: Following the extension vote, the Sponsor converted nearly all Founder Shares to Class A Ordinary Shares. The Sponsor also transferred 330,000 Founder Shares to certain investors in exchange for non-redemption agreements.
Investor Verification Checklist
- Trust Account Balance: Verify the current per-share redemption value following the significant redemptions in July 2026 (approx. $10.83 per share at the time of redemption).
- Liquidity Runway: Assess the sufficiency of the $321,957 operating cash balance and the terms of the $1.0 million Working Capital Note to sustain operations until the new January 2027 deadline.
- Share Count: Confirm the reduced number of outstanding Public Shares (1,773,611) and the impact on the Sponsor's ownership percentage and voting control.
- Extension Terms: Review the specific terms of the extension amendment and any additional capital contributions required from the Sponsor to maintain the listing or fund the search.